Concepedia

Mark P. Epping-Jordan

MP

Statistics

Publications

9

Citations

1.9K

H-Index

9

Active since

1998

Affiliations

Scripps Research Institute(Current)

Addex Therapeutics (Switzerland)

GlaxoSmithKline (Italy)

Institut Pasteur

University of Lausanne

Mark P. Epping-Jordan is an author at Scripps Research Institute specializing in neuroscience, neuropharmacology, and neurobiology.

Publications per year

1998–2023

9

Publications

9

Dramatic decreases in brain reward function during nicotine withdrawal

Mark P. Epping-Jordan, Shelly S. Watkins, George F. Koob et al. · Nature · 1998 · 677 citations

, , +16

Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice

Cristiano Chiamulera, Mark P. Epping-Jordan, Alessandro Zocchi et al. · Nature Neuroscience · 2001 · 549 citations

, , +14

Blockade of Nicotine Self-Administration with Nicotinic Antagonists in Rats

Shelly S. Watkins, Mark P. Epping-Jordan, George F. Koob et al. · Pharmacology Biochemistry and Behavior · 1999 · 237 citations

, , +14

The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat

Mark P. Epping-Jordan, A. Markou, George F. Koob · Brain Research · 1998 · 132 citations

, , +16

Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in αCGRP-deficient mice

Anne‐Marie Salmon, M. Imad Damaj, Lisa M. Marubio et al. · Nature Neuroscience · 2001 · 122 citations

, , +17

1–5 of 9